Skip to main content

Table 6 Established and potential serological markers of cardiomyopathy

From: Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis

Marker (mean ± SD) Low LGE High LGE P (Mann-Whitney U)
NT-proBNP [ng/L] 125.3 ± 82.2 101.8 ± 64.1 0.18
hs-TNT [ng/L] 5.6 ± 4.2 7.4 ± 3.8 0.56
sFLT1 [ng/L] 143.7 ± 22.6 77.1 ± 21.2 0.06
PLGF [ng/mL] 36.8 ± 10.3 20.6 ± 2.2 0.02
  1. hsTNT high sensitivity cTNT, LGE late gadolinium enhancement, NT-proBNP N-terminal prohormone brain natiuretic peptide, hsTNT high sensitivity cTNT, sFLT1 soluble short form of vascular endothelial growth factor receptor-1, PLGF placental growth factor